Learn about the global convalescent plasma therapy market through The Business Research Company, which provides information on convalescent plasma therapy market size, convalescent plasma therapy market drivers and restraints, convalescent plasma therapy market players, the COVID-19 impact on the convalescent plasma therapy market, and more.

The global convalescent plasma therapy market size is expected to grow from $0.036 billion in 2021 to $0.041 billion in 2022 at a compound annual growth rate (CAGR) of 11.4%. The change in the market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2021. The convalescent plasma therapy market is expected to reach $0.063 billion in 2026 at a CAGR of 11.5%.

Higher efficacy and safety evaluated during the trials conducted for CPT in COVID-19 patients can drive the market growth during the forecast period.

Request A Sample For The Global Convalescent Plasma Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smph

The convalescent plasma therapy market consists of sales of convalescent plasma obtained from patients who have recovered from an infection. Convalescent plasma is the plasma collected from the recovered or convalesced people consisting of the antibodies against the infection causing microorganism. The revenue generated by the market includes the sales of convalescent plasma collected from people post-infection, which will be utilized for prophylaxis and treatment of infected patients with the respective microorganism.

Global Convalescent Plasma Therapy Market Segments Include:

By Application: Prophylaxis, Treatment

By End-Users: Hospitals & Clinics, Laboratories & Research Institutes

By Antibody Type: IgM, IgG, IgA

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

The development of antibody-based immunotherapy as a potential therapeutic intervention for COVID-19 shows opportunities for the convalescent plasma therapy market. Convalescent plasma therapy utilizes the antibodies produced against coronavirus by the donor to improve the immunity of the recipient. Companies are initiating trials, collaborating and investing for antibody-based COVID-19 therapy.

TBRC’s convalescent plasma therapy market report covers:

Major Market Players: Bio Farma, Grifols, Hilton Pharma, Biotest, BPL, LFB, Octapharma, CSL Behring, Takeda Pharmaceutical Company Limited, and Orthosera Kft.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Convalescent Plasma Therapy Global Market Report 2022 -Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides convalescent plasma therapy market overviews, analyzes and forecasts market size, share, convalescent plasma therapy market players, convalescent plasma therapy market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s convalescent plasma therapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Plasma Therapy Global Market Report 2021

Blood And Blood Components Global Market Report 2022

Blood Transfusion Diagnostics Global Market Report 2021

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read More About Us At https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info

Found This Article Helpful? Share It On: